Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

NCT00665366 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

493

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder Mania

Interventions

DRUG: Aripiprazole
DRUG: Placebo
DRUG: Lithium
DRUG: Valproate

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]